Genomics-Driven Healthcare: Trends in Disease Prevention and Treatment
Editat de Yashwant Pathaken Limba Engleză Hardback – 11 iul 2018
Following the genome studies released in early part of this century, the advent of the -Omics sciences (genomics and pharmacogenomics, proteomics, metabolomics, transcriptomics) has seen the expansion of a vast knowledgebase with utility in preventing and treating disease, and improving health for all. Bioinformatics and improved pharmacogenetic understanding forge a path for improved drug discovery and design methods accounting for differences in delivery and disposition across populations.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1029.64 lei 38-44 zile | |
| Springer Nature Singapore – 15 dec 2018 | 1029.64 lei 38-44 zile | |
| Hardback (1) | 1069.47 lei 38-44 zile | |
| Springer Nature Singapore – 11 iul 2018 | 1069.47 lei 38-44 zile |
Preț: 1069.47 lei
Preț vechi: 1407.19 lei
-24% Nou
Puncte Express: 1604
Preț estimativ în valută:
204.67€ • 213.23$ • 170.17£
204.67€ • 213.23$ • 170.17£
Carte tipărită la comandă
Livrare economică 07-13 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789811075056
ISBN-10: 9811075050
Pagini: 496
Ilustrații: XV, 409 p. 52 illus., 37 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0 kg
Ediția:1st ed. 2018
Editura: Springer Nature Singapore
Colecția Adis
Locul publicării:Singapore, Singapore
ISBN-10: 9811075050
Pagini: 496
Ilustrații: XV, 409 p. 52 illus., 37 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0 kg
Ediția:1st ed. 2018
Editura: Springer Nature Singapore
Colecția Adis
Locul publicării:Singapore, Singapore
V-ar putea interesa
-
-15%Preț: 683.26 lei802.74 lei -
Nanocarriers for Drug-Targeting Brain TumorsLalit Kumar-23%Preț: 1459.85 lei1906.84 lei -
Current Topics in Nonclinical Drug Development: Volume 1Pritam S. Sahota-9%Preț: 1211.62 lei1331.44 lei -
Learning from Disease in Pets: A ‘One Health’ Model for DiscoveryRebecca A. Krimins-18%Preț: 1518.71 lei1852.08 lei -
-18%Preț: 1264.56 lei1542.15 lei -
Miraculous Medicines and the Chemistry of Drug DesignNathan Keighley-15%Preț: 413.27 lei486.20 lei -
Therapeutic Medicinal Plants: From Lab to the MarketMarta C.T. DuartePreț: 453.08 lei -
Biopharmaceuticals: Challenges and OpportunitiesBasanta Behera-18%Preț: 1251.04 lei1525.66 lei -
Silkworm Biofactory: Silk to BiologyKatsumi Maenaka-26%Preț: 1018.00 lei1368.45 lei -
-26%Preț: 927.78 lei1251.50 lei -
Biointeractions of NanomaterialsVijaykumar B. Sutariya-25%Preț: 997.11 lei1334.83 lei -
Computational Methods for Drug RepurposingQuentin Vanhaelen-18%Preț: 942.21 lei1149.04 lei -
Rapid Microbiological Methods in the Pharmaceutical IndustryMartin C. Easter-26%Preț: 2243.71 lei3026.98 lei -
-18%Preț: 930.51 lei1134.77 lei -
-18%Preț: 985.40 lei1201.71 lei -
Dendrimers in Medical ScienceZahoor Ahmad Parry-15%Preț: 569.25 lei669.70 lei -
Surface Modification of Nanoparticles for Targeted Drug DeliveryYashwant V PathakPreț: 434.34 lei -
-18%Preț: 1097.73 lei1338.70 lei -
-9%Preț: 770.31 lei846.50 lei -
-18%Preț: 1377.29 lei1679.61 lei -
-24%Preț: 792.49 lei1042.74 lei -
-18%Preț: 994.07 lei1212.28 lei
Cuprins
Chapter 1. Rethinking drug discovery and targeting after the genomic revolution
Dharmesh R Chejara, Ravindra V Badhe, Pradeep Kumar, Yahya E Choonara, Lomas K Tomar, Charu Tyagi, Viness Pillay
Chapter 2. Living between sickness and health: Where is the human genome leading us?
Amy Broadwater, Yashwant Pathak
Chapter 3. Pharmacogenomics: Setting Newer Paradigms of Genetics in Therapy and Medicine
Sanjay Dey, Kumud Joshi, Bhaskar Mazumder
Chapter 4. Bioinformatics and Pharmacogenomics: Tools to Understand and Accelerate Infectious Disease Control
Ashwani sharma, Subrata Sinha, Surabhi Johari, Bhaskar Mazumder
Chapter 5. Race and Ethnicity – Understanding Difference in the Genome Era
Shannon Kelly, Yashwant Pathak
Chapter 6. The Food Metabolome and Novel Dietary Biomarkers Associated with Diseases
Orhan E Arslan, Philip Palmon
Chapter 7. Impact of genomics on drug discovery and clinical medicine
Deepak Gupta
Chapter 8. Genomics and drug transporters and application in drug discovery, delivery and development
Robert Gharavi, Hazem E. Hassan
Chapter 9. Genomics and drug metabolizing enzymes its application in Drug delivery: Evaluating the influence of the microbiome
Sheeba Varghese Gupta
Chapter 10. Essentials of Genomics in the Continuum of Translational Research
Sadaf Aslam
Chapter 11. Charting a course for genomic medicine from base pair to bedside
Teresa Vo
Chapter 12. Pharmacogenomics and pharmacoepigenomics: impact on therapeutic strategies
Kristopher R Hall, Tamer E. Fandy
Chapter 13. Clinical Pharmacogenomics and Personalized Medicine: New strategies to maximize drug efficacy and avoid adverse drug reaction
Chonlaphat Sukasem, Sadeep Medhasi
Chapter 14. Epigenetic Patterns/Therapies associated with Genetic Disorders
Mazzio Elizabeth, Soliman KFA
Chapter 15. Neurodegenerative disease conditions and genomic treatment for better health
Ravindra V. Badhe, Dharmesh R. Chejara, Pradeep Kumar, Yahya E. Choonara, Viness Pillay
Chapter 16. Recent Trends in -Omics based methods and techniques for Lung Diseases prevention
Raisah Salhab, Yashwant V Pathak
Chapter 17. Impact of Genomics on Personalization of Breast Cancer Care
F. Scott Heinemann, Alice Police, Erin Lin, Mandy Liu, Sherry Liang, Ying Huang
Chapter 18. Pharmacogenomics: a new approach for preventing severe cutaneous adverse drug reactions
Chonlaphat Sukasem, Therdpong Tempark
Dharmesh R Chejara, Ravindra V Badhe, Pradeep Kumar, Yahya E Choonara, Lomas K Tomar, Charu Tyagi, Viness Pillay
Chapter 2. Living between sickness and health: Where is the human genome leading us?
Amy Broadwater, Yashwant Pathak
Chapter 3. Pharmacogenomics: Setting Newer Paradigms of Genetics in Therapy and Medicine
Sanjay Dey, Kumud Joshi, Bhaskar Mazumder
Chapter 4. Bioinformatics and Pharmacogenomics: Tools to Understand and Accelerate Infectious Disease Control
Ashwani sharma, Subrata Sinha, Surabhi Johari, Bhaskar Mazumder
Chapter 5. Race and Ethnicity – Understanding Difference in the Genome Era
Shannon Kelly, Yashwant Pathak
Chapter 6. The Food Metabolome and Novel Dietary Biomarkers Associated with Diseases
Orhan E Arslan, Philip Palmon
Chapter 7. Impact of genomics on drug discovery and clinical medicine
Deepak Gupta
Chapter 8. Genomics and drug transporters and application in drug discovery, delivery and development
Robert Gharavi, Hazem E. Hassan
Chapter 9. Genomics and drug metabolizing enzymes its application in Drug delivery: Evaluating the influence of the microbiome
Sheeba Varghese Gupta
Chapter 10. Essentials of Genomics in the Continuum of Translational Research
Sadaf Aslam
Chapter 11. Charting a course for genomic medicine from base pair to bedside
Teresa Vo
Chapter 12. Pharmacogenomics and pharmacoepigenomics: impact on therapeutic strategies
Kristopher R Hall, Tamer E. Fandy
Chapter 13. Clinical Pharmacogenomics and Personalized Medicine: New strategies to maximize drug efficacy and avoid adverse drug reaction
Chonlaphat Sukasem, Sadeep Medhasi
Chapter 14. Epigenetic Patterns/Therapies associated with Genetic Disorders
Mazzio Elizabeth, Soliman KFA
Chapter 15. Neurodegenerative disease conditions and genomic treatment for better health
Ravindra V. Badhe, Dharmesh R. Chejara, Pradeep Kumar, Yahya E. Choonara, Viness Pillay
Chapter 16. Recent Trends in -Omics based methods and techniques for Lung Diseases prevention
Raisah Salhab, Yashwant V Pathak
Chapter 17. Impact of Genomics on Personalization of Breast Cancer Care
F. Scott Heinemann, Alice Police, Erin Lin, Mandy Liu, Sherry Liang, Ying Huang
Chapter 18. Pharmacogenomics: a new approach for preventing severe cutaneous adverse drug reactions
Chonlaphat Sukasem, Therdpong Tempark
Recenzii
“This is an update on the current understanding of pharmacogenomics, drug targets, and drug transporters. … This book appears to be written for practitioners and provides clinically relevant information that can be used in practice. … One of the unique aspects of this book is the focus on the implications of pharmacogenomics with respect to disease prevention, not merely treatment.” (Nicole Sifontis, Doody's Book Reviews, November, 2018)
Notă biografică
Dr Yashwant Pathak is the Associate Dean for Faculty Affairs and Full Professor in the College of Pharmacy, Morsani College of Medicine and College of Public Health at the University of South Florida (USF). He is an internationally recognized scholar, researcher and educator in the areas of health care education, nanotechnology, drug delivery systems and nutraceuticals.
Dr Pathak was awarded his MPharm and PhD from Nagpur University, India. He also holds an Executive MBA and Masters in Conflict Management from Sullivan University, Louisville, USA. His post-doctoral training was at Royal free Hospital London, UK, Hebrew University of Jerusalem, Israel and University of Michigan Medical Center at Ann Arbor, Michigan, USA.
In addition to his primary roles, Dr Pathak is also Professor at USF College of Social and Behavioral Sciences and USF College of Sustainability; Adjunct Professor at JSS University Mysore, India; holds adjunct appointments at the University of West Indies Arthur Lok Jack Graduate School of Business, Trinidad And Tobago, and the College of Business at USF for DBA programs; and is a member of the Advisory Board for NERC (Nanotechnology Education and Research Centre) College of Engineering, USF. Prior to these current appointments, he gained 9 years of experience as Dean at USF and 17 years as faculty and researcher. He has also worked as Chair of the International Working group for USF Health and Director of the Nano Center.Dr Pathak has over 150 research publications and over 22 edited books. He has presented his work in more than 100 national and international conferences. In the last two years he has been awarded the Fulbright Senior Scholar Core Fellowship Award 2015-2016 for Indonesia; the Endeavour Executive fellowship by Australian Government 2015 in collaboration with Deakin University; the CNPQ Brazil Government Fellowship; the Outstanding Achievement Award for Global Engagement by USF; the Outstanding faculty Award for USF March 2017; and been made a Fellow of NSF I-Corps USF 2016.
Dr Pathak was awarded his MPharm and PhD from Nagpur University, India. He also holds an Executive MBA and Masters in Conflict Management from Sullivan University, Louisville, USA. His post-doctoral training was at Royal free Hospital London, UK, Hebrew University of Jerusalem, Israel and University of Michigan Medical Center at Ann Arbor, Michigan, USA.
In addition to his primary roles, Dr Pathak is also Professor at USF College of Social and Behavioral Sciences and USF College of Sustainability; Adjunct Professor at JSS University Mysore, India; holds adjunct appointments at the University of West Indies Arthur Lok Jack Graduate School of Business, Trinidad And Tobago, and the College of Business at USF for DBA programs; and is a member of the Advisory Board for NERC (Nanotechnology Education and Research Centre) College of Engineering, USF. Prior to these current appointments, he gained 9 years of experience as Dean at USF and 17 years as faculty and researcher. He has also worked as Chair of the International Working group for USF Health and Director of the Nano Center.Dr Pathak has over 150 research publications and over 22 edited books. He has presented his work in more than 100 national and international conferences. In the last two years he has been awarded the Fulbright Senior Scholar Core Fellowship Award 2015-2016 for Indonesia; the Endeavour Executive fellowship by Australian Government 2015 in collaboration with Deakin University; the CNPQ Brazil Government Fellowship; the Outstanding Achievement Award for Global Engagement by USF; the Outstanding faculty Award for USF March 2017; and been made a Fellow of NSF I-Corps USF 2016.
Textul de pe ultima copertă
This book evaluates trends arising in “-Omics” sciences in terms of their current and potential future application to therapeutic design and understanding of disease. Chapters consider the impact of pharmacogenomics and bioinformatics on drug development, as well as trends in genomics, as applied to understanding of neurodegenerative and lung disease, psychiatry and oncology.
Following the genome studies released in early part of this century, the advent of the -Omics sciences (genomics and pharmacogenomics, proteomics, metabolomics, transcriptomics) has seen the expansion of a vast knowledgebase with utility in preventing and treating disease, and improving health for all. Bioinformatics and improved pharmacogenetic understanding forge a path for improved drug discovery and design methods accounting for differences in delivery and disposition across populations.
Following the genome studies released in early part of this century, the advent of the -Omics sciences (genomics and pharmacogenomics, proteomics, metabolomics, transcriptomics) has seen the expansion of a vast knowledgebase with utility in preventing and treating disease, and improving health for all. Bioinformatics and improved pharmacogenetic understanding forge a path for improved drug discovery and design methods accounting for differences in delivery and disposition across populations.
Caracteristici
Outlines steps for translating functional genomics into rational therapeutics
Describes recent trends in understanding the influence of genomics in disease and disease prevention
Provides understanding of the contribution of "-omics"-driven pharmaceuticals in delivering better health care
Describes recent trends in understanding the influence of genomics in disease and disease prevention
Provides understanding of the contribution of "-omics"-driven pharmaceuticals in delivering better health care